论文部分内容阅读
肿瘤细胞通过提高葡萄糖转运、加快糖酵解及形成肿瘤新生血管体系作为对微环境缺血、缺氧的代偿,其中通过摄入葡萄糖加强能量摄取是一条重要的途径。葡萄糖转运蛋白1(glucose transporter 1,GLUT-1)是一种组织细胞进行跨膜转运葡萄糖的重要载体,在哺乳动物胚胎和成熟组织中低水平表达,但在缺氧及缺血的恶性肿瘤细胞中表达显著增高,且与肿瘤进展、患者预后有着一定关系。在体外培养细胞系中,GLUT-1的调控可以分为急性调控和慢性调控两方面,其中缺氧诱导因子1等介导的涉及mRNA和蛋白合成的慢性调控是其主要调控方式。应用免疫组织化学、RT-PCR等方法检测GLUT-1在肿瘤组织的表达,可为肿瘤的诊断提供新的途径。以GLUT-1为靶点从根本上阻断肿瘤能量来源的手段可为肿瘤治疗提供新的策略。
Tumor cells increase glucose transport, accelerate glycolytic and tumor neovascularization as compensation for ischemia and hypoxia in microenvironment, and energy intake through glucose uptake is an important way. Glucose transporter 1 (GLUT-1) is an important carrier of glucose transporter cells transmembrane transport in mammalian embryos and mature tissues at low levels, but in hypoxic and ischemic malignant cells In the expression was significantly higher, and with the progress of cancer, the prognosis of patients has a certain relationship. In vitro cell lines, GLUT-1 regulation can be divided into acute regulation and chronic regulation in two aspects, including hypoxia inducible factor 1 and other involved in the regulation of mRNA and protein synthesis is the main control. Using immunohistochemistry and RT-PCR to detect the expression of GLUT-1 in tumor tissue can provide a new way for the diagnosis of tumors. The means of fundamentally blocking the energy source of tumor by targeting GLUT-1 can provide a new strategy for cancer therapy.